Seeking Alpha

Acura Pharmaceuticals (ACUR) has been awarded a patent by the USPTO relating to its Aversion...

Acura Pharmaceuticals (ACUR) has been awarded a patent by the USPTO relating to its Aversion polymer matrix technology when utilized with any water soluble drug of abuse, as well as certain opioid products being developed by the company. Certain claims in this patent are licensed to Pfizer (PFE) which utilizes the Aversion technology in its Oxecta tablets.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector